Page last updated: 2024-08-17

physostigmine and Behavior Disorders

physostigmine has been researched along with Behavior Disorders in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-199017 (94.44)18.7374
1990's1 (5.56)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MIDRIO, M; XAMIN, E1
STOLIAROV, GV1
Brichcín, S; Filipová, A1
Bahro, M; Berger, M; Gann, H; Hohagen, F; Lis, S; Riemann, D; Stadmüller, G1
Enna, SJ1
Luauté, JP; Thionville, M1
Bourgeois, M1
Hussey, HH1
Gillin, JC; Huey, LY; Janowsky, DS; Kalir, HH; Kennedy, B; Mott, MA; Risch, SC; Turken, A; Ziegler, M1
Huey, LY; Janowsky, DS; Rausch, JL; Risch, SC1
Ambani, LM; Sethy, VH; Van Woert, MH1
Davis, JM1
Constantinidis, J1
Modestin, J1
Ambani, LM; Bowers, MB; Van Woert, MH1
Bilikiewicz, T; Galuszko, P1
Leczycka, K; Trembla, K1

Reviews

1 review(s) available for physostigmine and Behavior Disorders

ArticleYear
Neurobiology and pharmacology of Huntington's disease.
    Life sciences, 1977, Jan-15, Volume: 20, Issue:2

    Topics: Brain; Carnosine; Choline O-Acetyltransferase; Cholinergic Fibers; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Humans; Huntington Disease; Mental Disorders; Movement; Nerve Degeneration; Norepinephrine; Peptidyl-Dipeptidase A; Physostigmine; Receptors, Muscarinic; Receptors, Neurotransmitter; Serotonin; Tranquilizing Agents

1977

Trials

3 trial(s) available for physostigmine and Behavior Disorders

ArticleYear
Cholinergic neurotransmission, REM sleep and depression.
    Journal of psychosomatic research, 1994, Volume: 38 Suppl 1

    Topics: Adolescent; Adult; Aged; Alzheimer Disease; Brain Stem; Cholinergic Agonists; Cholinergic Fibers; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Mental Disorders; Middle Aged; Parasympathomimetics; Physostigmine; Polysomnography; Reaction Time; Receptors, Muscarinic; Sleep Stages; Sleep Wake Disorders; Sleep, REM; Succinimides; Synaptic Transmission; Tacrine

1994
Central and peripheral cholinesterase inhibition: effects on anterior pituitary and sympathomimetic function.
    Psychoneuroendocrinology, 1986, Volume: 11, Issue:2

    Topics: Adrenocorticotropic Hormone; Catecholamines; Endorphins; Humans; Hydrocortisone; Male; Mental Disorders; Neostigmine; Physostigmine; Pituitary Gland, Anterior; Pituitary Hormones, Anterior; Sympathetic Nervous System

1986
[Pathogenesis of delirious states].
    Confinia psychiatrica. Borderland of psychiatry. Grenzgebiete der Psychiatrie. Les Confins de la psychiatrie, 1974, Volume: 17, Issue:1

    Topics: Adult; Aged; Alcoholism; Clinical Trials as Topic; Delirium; Drug Evaluation; Female; Humans; Male; Mental Disorders; Middle Aged; Physostigmine; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranquilizing Agents

1974

Other Studies

14 other study(ies) available for physostigmine and Behavior Disorders

ArticleYear
[Action of adrenaline on the partially depressed neuro-muscular transmission of eserine].
    Archivio italiano di scienze farmacologiche, 1961, Volume: 11

    Topics: Epinephrine; Mental Disorders; Muscles; Neuromuscular Junction; Physostigmine

1961
[ON ATROPINE PSYCHOSES].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1963, Volume: 63

    Topics: Atropine; Humans; Mental Disorders; Morphine; Physostigmine; Pilocarpine; Psychoses, Substance-Induced; Psychotic Disorders; Toxicology

1963
[2 years of experience with cholinergolytic comas].
    Ceskoslovenska psychiatrie, 1967, Volume: 63, Issue:4

    Topics: Adolescent; Adult; Atropine; Coma; Female; Humans; Injections, Intramuscular; Male; Mental Disorders; Middle Aged; Physostigmine; Scopolamine

1967
[Anti-cholinergic confusional states connected with chemotherapy of mental diseases: value of eserine sulfate (physostigime)].
    La Nouvelle presse medicale, 1978, Jun-03, Volume: 7, Issue:22

    Topics: Cognition Disorders; Confusion; Depression; Humans; Mental Disorders; Physostigmine; Psychotropic Drugs; Schizophrenia

1978
[Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital].
    L'Encephale, 1977, Volume: 3, Issue:4

    Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Chlorpromazine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Female; France; Humans; Iatrogenic Disease; Male; Mental Disorders; Middle Aged; Physostigmine; Reserpine; Retrospective Studies; Tranquilizing Agents; Tyrosine

1977
Letter: Clinical observations in ECT.
    The American journal of psychiatry, 1975, Volume: 132, Issue:8

    Topics: Electroconvulsive Therapy; Female; Humans; Language Disorders; Male; Mental Disorders; Middle Aged; Parasympatholytics; Physostigmine

1975
Editorial: Physostigmine: value in treatment of central toxic effects of anti-cholinergic drugs.
    JAMA, 1975, Mar-10, Volume: 231, Issue:10

    Topics: Amitriptyline; Benztropine; Brain; Doxepin; Haloperidol; Humans; Injections, Intramuscular; Mental Disorders; Parasympatholytics; Physostigmine; Thioridazine

1975
A kinetic analysis and replication of decreased platelet serotonin uptake in depressed patients.
    Psychiatry research, 1986, Volume: 19, Issue:2

    Topics: Bipolar Disorder; Blood Platelets; Depressive Disorder; Humans; Kinetics; Mental Disorders; Mood Disorders; Physostigmine; Serotonin

1986
Effect of phenothiazines on central cholinergic activity.
    Advances in biochemical psychopharmacology, 1974, Volume: 9, Issue:0

    Topics: Acetylcholine; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Brain Chemistry; Chlorpromazine; Choline; Cholinesterase Inhibitors; Cholinesterases; Female; Humans; Male; Mental Disorders; Parasympathetic Nervous System; Parkinson Disease, Secondary; Physostigmine; Reserpine; Time Factors; Tremor; Trifluoperazine

1974
Psychopharmacology in the aged. Use of psychotropic drugs in geriatric patients.
    Journal of geriatric psychiatry, 1974, Volume: 7, Issue:2

    Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Depression; Dihydroergotoxine; Drug Interactions; Electroconvulsive Therapy; Gonadal Steroid Hormones; Guanethidine; Haloperidol; Humans; Lithium; Mental Disorders; Physostigmine; Psychotropic Drugs; Schizophrenia; Thiothixene; Thioxanthenes; Vitamins

1974
[Monoamines and choreic syndromes].
    Revue neurologique, 1972, Volume: 127, Issue:1

    Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus; Homovanillic Acid; Humans; Huntington Disease; Mental Disorders; Methyldopa; Methyltyrosines; Models, Neurological; Movement Disorders; Phenothiazines; Physostigmine; Reserpine; Thalamus; Tranquilizing Agents; Tyrosine

1972
Physostigmine effects on phenothiazine-induced extrapyramidal reactions.
    Archives of neurology, 1973, Volume: 29, Issue:6

    Topics: Adult; Antiparkinson Agents; Chlorpromazine; Drug Hypersensitivity; Extrapyramidal Tracts; Female; Handwriting; Humans; Male; Mental Disorders; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Physostigmine; Salicylates; Schizophrenia; Substance-Related Disorders; Time Factors; Trifluoperazine; Tropanes

1973
[Atropine coma and its therapeutic value].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1970, Volume: 25, Issue:37

    Topics: Atropine; Chronic Disease; Coma; Humans; Mental Disorders; Neurotic Disorders; Physostigmine; Psychotic Disorders; Schizophrenia

1970
The course and consequences of coma after huge doses of atropine.
    Polish medical journal, 1969, Volume: 8, Issue:2

    Topics: Adult; Atropine; Coma; Humans; Mental Disorders; Middle Aged; Physostigmine

1969